IP Library Granted Patent US 12,064,334
Granted Patent B2
US 12,064,334 · App. 16/893,296 · Granted Aug 20, 2024

Reinforced orthopedic devices

Inventors: E. Skott Greenhalgh (Gladwyne, PA); Antony Koblish (Malvern, PA)
Assignee: Tela Bio, Inc.
A61F2/08A61F2/0811A61F2002/0858A61F2002/087
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,064,334
App. No.
16/893,296
Granted
Aug 20, 2024
Kind
B2
Abstract

Implantable tensile load-bearing grafts having synthetic components stitched through biological components are disclosed. The synthetic components can be biodegradable and/or non-biodegradable and of differing tensile strengths from each other and the biological component. Methods of making the grafts are also disclosed.

Claims (39)

1. An implantable orthopedic device for implantation as a tensile load bearing element in a target site comprising:

a biological component comprising a soft tissue and a hard tissue;

a first synthetic component configured to sustain a first portion of a tensile load; and

a second synthetic component configured to sustain a second portion of the tensile load,

wherein the second synthetic component extends in multiple directions through the soft tissue and through the hard tissue,

wherein the hard tissue has a hard tissue length, a hard tissue width, and a hard tissue height, wherein the hard tissue length is greater than the hard tissue width and the hard tissue height,

wherein the soft tissue has a soft tissue length, a soft tissue width, and a soft tissue height, wherein the soft tissue length is greater than the soft tissue width and the soft tissue height,

wherein the second synthetic component extends through the hard tissue along the hard tissue length and through the soft tissue along the soft tissue length,

wherein the hard tissue comprises a hard tissue first channel and a hard tissue second channel, wherein the hard tissue first channel is the same distance from a longitudinal center of the biological component as the hard tissue second channel,

wherein the hard tissue first channel has multiple turns, and wherein the second synthetic component extends along the multiple turns.

2. The implantable orthopedic device of claim 1 ,

wherein the biological component has a longitudinal axis that extends along the soft tissue and the hard tissue,

wherein the first synthetic component is configured to sustain the first portion of the tensile load along the longitudinal axis, wherein the first synthetic component extends through the soft tissue along the longitudinal axis, and

wherein the second synthetic component is configured to sustain the second portion of the tensile load along the longitudinal axis, wherein the second synthetic component extends through the soft tissue and the hard tissue along the longitudinal axis.

3. The implantable orthopedic device of claim 1 , wherein the second synthetic component extends through the soft tissue and the hard tissue such that the second synthetic component sequentially extends from the hard tissue, into the soft tissue, and then back into the hard tissue.

4. The implantable orthopedic device of claim 1 , wherein the second synthetic component is stitched through the soft tissue and the hard tissue.

5. The implantable orthopedic device of claim 1 , wherein a total length of the first synthetic component is greater than the soft tissue length, and wherein a total length of the second synthetic component is greater than the hard tissue length.

6. The implantable orthopedic device of claim 1 , wherein a total length of the first synthetic component is greater than the hard tissue length, and wherein a total length of the second synthetic component is greater than the hard tissue length.

7. The implantable orthopedic device of claim 1 , wherein a total length of the first synthetic component is greater than a total length of the biological component, and wherein a total length of the second synthetic component is greater than the hard tissue length.

8. The implantable orthopedic device of claim 1 , wherein the second synthetic component overlaps with the first synthetic component.

9. The implantable orthopedic device of claim 1 , wherein the soft tissue comprises at least one of a ligament, a tendon, and a muscle.

10. The implantable orthopedic device of claim 1 , wherein the hard tissue comprises a first bone plug at a first end of the device and a second bone plug at a second end of the device.

11. The implantable orthopedic device of claim 1 ,

wherein the hard tissue has a hard tissue first longitudinal terminal end and a hard tissue second longitudinal terminal end,

wherein the soft tissue has a soft tissue first longitudinal end, a soft tissue second longitudinal end, and a soft tissue longitudinal center between the soft tissue first longitudinal end and the soft tissue second longitudinal end,

wherein the hard tissue first longitudinal terminal end and the hard tissue second longitudinal terminal end are closer to the soft tissue first longitudinal end than to the soft tissue longitudinal center,

wherein the hard tissue first longitudinal terminal end is closer to the soft tissue longitudinal center than the hard tissue second longitudinal terminal end,

wherein a first portion of the second synthetic component is between the hard tissue first longitudinal terminal end and the hard tissue second longitudinal terminal end, and

wherein a second portion of the second synthetic component is between the hard tissue first longitudinal terminal end and the soft tissue longitudinal center.

12. The implantable orthopedic device of claim 11 , wherein the first synthetic component overlaps with the second synthetic component in the soft tissue.

13. The implantable orthopedic device of claim 11 , wherein the first synthetic component extends across the second synthetic component in the soft tissue.

14. The implantable orthopedic device of claim 11 , wherein a length of the second synthetic component is greater than the soft tissue length.

15. The implantable orthopedic device of claim 11 , wherein a length of the second synthetic component is greater than the hard tissue length, and wherein the length of the second synthetic component is greater than the soft tissue length.

16. The implantable orthopedic device of claim 11 , wherein a total length of the second synthetic component is greater than the hard tissue length as measured from the hard tissue first longitudinal terminal end to the hard tissue second longitudinal terminal end.

17. The implantable orthopedic device of claim 1 , wherein the first synthetic component extends in multiple directions back and forth from a biological component first lateral side to a biological component second lateral side, and wherein the first synthetic component extends through the soft tissue along the soft tissue length.

18. The implantable orthopedic device of claim 1 , wherein a length of the second synthetic component in the hard tissue first channel is greater than a length of the hard tissue.

19. The implantable orthopedic device of claim 1 , wherein the implantable orthopedic device has a first longitudinal end and a second longitudinal end opposite the first longitudinal end, wherein the first longitudinal end comprises the hard tissue, and wherein the second longitudinal end comprises the soft tissue.

20. The implantable orthopedic device of claim 19 , wherein the first longitudinal end further comprises the soft tissue.

21. The implantable orthopedic device of claim 1 , wherein the first synthetic component extends through the soft tissue along the soft tissue length.

Assignments (6)
SECURITY INTEREST Recorded Nov 14, 2025
From: TELA BIO, INC.
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 072905/0537 →
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2025
From: MIDCAP FINANCIAL TRUST
To: TELA BIO, INC.
Reel/Frame 072912/0103 →
SECURITY INTEREST Recorded Aug 24, 2022
From: TELA BIO, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 060888/0633 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2020
From: GREENHALGH, E. SKOTT; KOBLISH, ANTONY
To: ATHLETA MEDICAL, INC.
Reel/Frame 052844/0807 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2020
From: ATHLETA MEDICAL, INC.
To: INITIUM MEDICAL, LLC
Reel/Frame 052844/0813 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2020
From: INITIUM MEDICAL, LLC
To: TELA BIO, INC.
Reel/Frame 052844/0832 →